Immutep (IMMP) Cash & Equivalents (2018 - 2025)
Historic Cash & Equivalents for Immutep (IMMP) over the last 12 years, with Q2 2025 value amounting to $43.2 million.
- Immutep's Cash & Equivalents fell 5951.14% to $43.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $43.2 million, marking a year-over-year decrease of 5951.14%. This contributed to the annual value of $43.2 million for FY2025, which is 5951.14% down from last year.
- As of Q2 2025, Immutep's Cash & Equivalents stood at $43.2 million, which was down 5951.14% from $48.3 million recorded in Q4 2024.
- In the past 5 years, Immutep's Cash & Equivalents registered a high of $106.6 million during Q2 2024, and its lowest value of $43.2 million during Q2 2025.
- For the 5-year period, Immutep's Cash & Equivalents averaged around $63.3 million, with its median value being $57.3 million (2022).
- Its Cash & Equivalents has fluctuated over the past 5 years, first soared by 17046.18% in 2021, then plummeted by 5951.14% in 2025.
- Over the past 5 years, Immutep's Cash & Equivalents (Quarter) stood at $72.6 million in 2021, then crashed by 38.12% to $44.9 million in 2022, then skyrocketed by 50.32% to $67.5 million in 2023, then decreased by 28.45% to $48.3 million in 2024, then dropped by 10.65% to $43.2 million in 2025.
- Its Cash & Equivalents stands at $43.2 million for Q2 2025, versus $48.3 million for Q4 2024 and $106.6 million for Q2 2024.